Catalent Inc (CTLT) Return on Equity ROE from the first quarter 2025 to first quarter 2024 and annually, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Catalent Inc   (NYSE: CTLT)

Catalent Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Catalent Inc in the first quarter 2025?
Catalent Inc recorded a cumulative net loss of $-413 million during 12 months ending in the first quarter 2025, resulting in a negative return on equity (ROE) of -10.64%.

Within the Major Pharmaceutical Preparations industry 67 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2024 from 2337 to 2545.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2024)
I. Quarter		 (Jun 30 2024)
IV. Quarter		 (Mar 31 2024)
III. Quarter		 (Dec 31 2023)
II. Quarter		 (Sep 30 2023)
I. Quarter
Y / Y Equity Change 7.98 % -7.78 % -21.84 % -23.22 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -413 -1,043 -1,176 -1,302 -1,015
Return On Equity (TTM) -10.64 % -27.49 % -30.39 % -31.59 % -23.1 %
CTLT's Total Ranking # 2545 # 2337 # 2390 # 2616 # 0
Equity (TTM) in Millions 4,775 3,542 3,604 3,611 4,422
Seq. Equity Change 34.81 % -1.72 % -0.19 % -18.34 % 15.13 %
Seq. Net Income Change - - - - -

Back to CTLT Management Effectiveness >> CTLT's 5 Years Annual ROE >> Compare CTLT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 68
Sector # 224
Overall # 2545

Return On Equity Statistics
High Average Low
43.64 %
8.68 %
-30.92 %
(Sep. 30, 2015)   (Dec 31 2023)





CTLT Annual Return On Equity (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021		 (Jun 30 2020)
2020
Total Equity in Millions 3,604 4,611 4,775 3,915 2,899
Y / Y Equity Change -21.84 % -3.43 % 21.97 % 35.06 % 72.38 %
Net Income in Millions -1,043 -256 483 529 173
Y / Y Net Income Change - - -8.7 % 205.78 % 25.91 %
Return On Equity -28.94 % -5.55 % 10.12 % 13.51 % 5.97 %

Back to CTLT Management Effectiveness >> CTLT's 5 Years Annual ROE >> Compare CTLT ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CTLT's' Return on Equity at Yahoo Finance
CTLT's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CTLT's Competitors
Subscribers only: Roe for Catalent Inc 's Suppliers
Subscribers only: Return On Equity for CTLT's Customers




Companies with similar Return On Equity at Sep 30 2024, within Healthcare Sector ROE

Date modified: 2026-09-26T06:52:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.